S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Health and Healthcare

IPO FILING: AutoGenomics Inc.

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
Follow 24/7 Wall St. on Google
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

AutogenomicsApparently the IPO filing hiatus isn’t entirely a dead end story.  A company called AutoGenomics, Inc. has filed a registration statement for a proposed initial public offering.  It has applied for the ticker "AGMX" on NASDAQ.

The share count and the pricing of this IPO are not yet determined, but it listed the "up to"amount as $86.3 million for filing purposes.  All shares in the offering will be sold by the company rather than insiders.

The company lists J.P. Morgan Securities as the sole book-runner andalso lists Deutsche Bank Securities as co-lead manager.  Co-managersare listed as Pacific Growth Equities and Robert W. Baird & Co.

The company designs, develops, manufactures and markets a fullyintegrated molecular diagnostics system called the INFINITI™ thatautomates the discrete processes of genetic testing performed byclinical laboratories.  It already holds trademarks of INFINITI™,BioFilmChip™, Intellipac™ and Qmatic™, and it received market approvalfrom the FDA for its INFINITI™ system.

Jon C. Ogg
July 25, 2008

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Half of America Still Feels Financially Exposed Despite 8% Jump in Security
David Beren |

Half of America Still Feels Financially Exposed Despite 8% Jump in Security
52% of Americans Are Building Wealth While Ignoring Their Greatest Risk
David Beren |

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

Continue Reading

Chris Lange |

AutoGenomics Files for IPO — Sorry, Files Again

AutoGenomics has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.
Douglas A. McIntyre |

IPO FILING: BioTrove, Inc. (BTRV)

A company called BioTrove, Inc. has filed to come public via an initial public offering this morning.  It has applied…
Paul Ausick |

Cloud Storage Firm Box Reloads, Sets Terms for Hot IPO

Cloud-based storage and collaboration platform Box has set terms for its initial public offering. The company first filed for an…
Douglas A. McIntyre |

IPO FILING: Salient Surgical Technologies, Inc. (SLNT, MDT)

Salient Surgical Technologies, Inc. has filed to come public via an initial public offering and has applied to trade on…
Neon Therapeutics Closes in on IPO
Chris Lange |

Neon Therapeutics Closes in on IPO

Neon Therapeutics filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering.…
Douglas A. McIntyre |

Nissan’s Big New Hybrid

Nissan’s flagship brand is Infiniti which competes with BMW, Mercedes, the Lexus brand of Toyota (NYSE: TM), and the Acura…
Jon C. Ogg |

Many Pending Tech, Internet, Media, Software IPOs On Deck, the 2010 Vintage (BSFT, CNVO, DVOX, EVDY, EYEB, FTEN, GFLY, GLAS, IRON, MX, MOTR, INTC, QCOM, SQI, TELX, VRNG)

The recent strength of the market has invigorated the waves of offerings.  Just last week we had seen some 16…
SI-Bone Announces Potential Pricing for IPO
Chris Lange |

SI-Bone Announces Potential Pricing for IPO

Medical device company SI-Bone intends to list 6 million shares in an initial public offering valued up to more than…
Jon C. Ogg |

Waves of Secondary Offerings Piling into Market Strength (DRTX, INFI, RLGY, RXN, SGYP, TRNX, CYCC, DG, APO)

ThinkstockWhat is one trend you see whenever the stock market hits a new high or enjoys a long period of…

Top Gaining Stocks

Cboe Global Markets
CBOE • Vol: 1,568,143
New Pluto Global
PSKY • Vol: 12,285,993
Seagate Technology
STX • Vol: 7,378,346
Oracle
ORCL • Vol: 26,317,675
Datadog
DDOG • Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ • Vol: 4,367,433
Clorox
CLX • Vol: 13,260,523
Stryker
SYK • Vol: 4,519,455
Mohawk Industries
MHK • Vol: 1,859,865
Amgen
AMGN • Vol: 3,818,618